These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
117 related items for PubMed ID: 8221402
1. Iodine replacement in fibrocystic disease of the breast. Ghent WR, Eskin BA, Low DA, Hill LP. Can J Surg; 1993 Oct; 36(5):453-60. PubMed ID: 8221402 [Abstract] [Full Text] [Related]
2. [Effect of iodine and thyroid hormones in the induction and therapy of Hashimoto's thyroiditis]. Rink T, Schroth HJ, Holle LH, Garth H. Nuklearmedizin; 1999 Oct; 38(5):144-9. PubMed ID: 10488481 [Abstract] [Full Text] [Related]
3. Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study. Okun MS, Fernandez HH, Rodriguez RL, Romrell J, Suelter M, Munson S, Louis ED, Mulligan T, Foster PS, Shenal BV, Armaghani SJ, Jacobson C, Wu S, Crucian G. Arch Neurol; 2006 May; 63(5):729-35. PubMed ID: 16682542 [Abstract] [Full Text] [Related]
4. Lithium as adjuvant to radioiodine therapy in differentiated thyroid carcinoma: clinical and in vitro studies. Liu YY, van der Pluijm G, Karperien M, Stokkel MP, Pereira AM, Morreau J, Kievit J, Romijn JA, Smit JW. Clin Endocrinol (Oxf); 2006 Jun; 64(6):617-24. PubMed ID: 16712662 [Abstract] [Full Text] [Related]
5. The effect of supraphysiologic levels of iodine on patients with cyclic mastalgia. Kessler JH. Breast J; 2004 Jun; 10(4):328-36. PubMed ID: 15239792 [Abstract] [Full Text] [Related]
12. The effect of growth hormone substitution on cognitive performance in adult patients with hypopituitarism. Oertel H, Schneider HJ, Stalla GK, Holsboer F, Zihl J. Psychoneuroendocrinology; 2004 Aug; 29(7):839-50. PubMed ID: 15177699 [Abstract] [Full Text] [Related]
13. Pilot study of urinary iodine concentration and of biochemical thyroid parameters before and after cautious public health intervention on salt iodide content: the Swiss longitudinal 1996-2000 iodine study. Als C, Haldimann M, Minder C, Gerber H. Eur J Clin Nutr; 2004 Aug; 58(8):1201-10. PubMed ID: 15226756 [Abstract] [Full Text] [Related]
14. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism. Romão R, Rubio IG, Tomimori EK, Camargo RY, Knobel M, Medeiros-Neto G. Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745 [Abstract] [Full Text] [Related]
15. [Clinical trial on mastoplasia treated by xiaozheng pills (qing xiang pills)]. Zong HX, Zhao CJ, Zhao CZ, Liang XL, Zhu ZY. Zhongguo Zhong Yao Za Zhi; 2006 Sep; 31(18):1545-7. PubMed ID: 17144474 [Abstract] [Full Text] [Related]
16. Hormone therapy in women in the menopause transition. Randomised, double-blind, placebo-controlled trial of effects on body weight, blood pressure, lipoprotein levels, antithrombin III activity, and the endometrium. Khoo SK, Coglan MJ, Wright GR, DeVoss KN, Battistutta D. Med J Aust; 1998 Mar 02; 168(5):216-20. PubMed ID: 9539899 [Abstract] [Full Text] [Related]
17. Misoprostol in the treatment of tinnitus: a double-blind study. Yilmaz I, Akkuzu B, Cakmak O, Ozlüoglu LN. Otolaryngol Head Neck Surg; 2004 May 02; 130(5):604-10. PubMed ID: 15138428 [Abstract] [Full Text] [Related]
18. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R. Clin Ther; 2006 Feb 02; 28(2):266-79. PubMed ID: 16678648 [Abstract] [Full Text] [Related]
19. Treatment of mastalgia with tamoxifen in male patients with liver cirrhosis: a randomized crossover study. Li CP, Lee FY, Hwang SJ, Chang FY, Lin HC, Kuo BI, Chu CJ, Lee SD. Am J Gastroenterol; 2000 Apr 02; 95(4):1051-5. PubMed ID: 10763958 [Abstract] [Full Text] [Related]
20. Treatment of benign fibrocystic disease of the breast with 2-bromo-alpha-ergocryptine (CB 154). Santoro C, Cappa M, Moretti C, Fabbri A, La Vecchia V, Romano Marcellino L, Fraioli F. Int J Clin Pharmacol Ther Toxicol; 1982 Oct 02; 20(10):479-81. PubMed ID: 6815107 [Abstract] [Full Text] [Related] Page: [Next] [New Search]